Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.

Guo NF, Cao YJ, Chen X, Zhang Y, Fan YP, Liu J, Chen XL

DOI: 10.26355/eurrev_201905_17832
Published: 2019 May
Container: European review for medical and pharmacological sciences
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201905_17832,
  title = {Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.},
  author = {Guo NF and Cao YJ and Chen X and Zhang Y and Fan YP and Liu J and Chen XL},
  year = {2019},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201905_17832},
  url = {https://doi.org/10.26355/eurrev_201905_17832}
}

RIS

TY  - JOUR
TI  - Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.
AU  - Guo NF
AU  - Cao YJ
AU  - Chen X
AU  - Zhang Y
AU  - Fan YP
AU  - Liu J
AU  - Chen XL
PY  - 2019
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201905_17832
UR  - https://doi.org/10.26355/eurrev_201905_17832
ER  -

APA

NF, G., YJ, C., X, C., Y, Z., YP, F., J, L., & XL, C. (2019). Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201905_17832

Source records

pubmed · retrieved 2026-09-25T03:52:45.157Z